June 20, 2026 India at the Forefront of Biomedical Innovation: A Unique Approach to Address Global Health
June 19, 2026 MAGE-A4/MAGE-A8-Targeted TCR-Based Bispecific T Cell Engager in Recurrent and/or Refractory Solid Tumors: A Phase 1 Trial